Proton therapy developer Ion Beam Applications (IBA) has signed a contract for its proton therapy system with a Chinese company.
Guangdong Hengju Medical Technologies of Guangzhou will install the unit, the first proton therapy system in southern China, the company said. The agreement is worth 30 million euros ($37.3 million U.S.).
IBA will provide the new center with equipment from its ProteusPlus system, which will also include IBA's pencil-beam scanning capability. The facility will open in the summer of 2017, according to the company.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
